Ascelia Pharma AB Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
November 08, 2023 at 01:30 am EST
Ascelia Pharma AB (publ) reported earnings results for the third quarter and nine months ended September 30, 2023. For the third quarter, the company reported net loss was SEK 21.22 million compared to SEK 25.96 million a year ago. Basic loss per share from continuing operations was SEK 0.63 compared to SEK 0.77 a year ago.
For the nine months, net loss was SEK 98.69 million compared to SEK 77.84 million a year ago. Basic loss per share from continuing operations was SEK 2.93 compared to SEK 2.25 a year ago.